AU4515885A - Creation of Inventions and Patents with Artificial Intelligence

AU4515885A – New tetrapyrrole therapeutic agents
– Google Patents

AU4515885A – New tetrapyrrole therapeutic agents
– Google Patents
New tetrapyrrole therapeutic agents

Info

Publication number
AU4515885A

AU4515885A
AU45158/85A
AU4515885A
AU4515885A
AU 4515885 A
AU4515885 A
AU 4515885A
AU 45158/85 A
AU45158/85 A
AU 45158/85A
AU 4515885 A
AU4515885 A
AU 4515885A
AU 4515885 A
AU4515885 A
AU 4515885A
Authority
AU
Australia
Prior art keywords
tetrapyrrole
new
therapeutic agents
carboxy group
aminodicarboxylic acid
Prior art date
1984-07-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU45158/85A
Other versions

AU579387B2
(en

Inventor
Jerry C. Bommer
Bruce F. Burnham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eneos Corp

Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-07-18
Filing date
1985-07-18
Publication date
1986-03-27

1985-07-18
Application filed by Nippon Petrochemicals Co Ltd
filed
Critical
Nippon Petrochemicals Co Ltd

1986-03-27
Publication of AU4515885A
publication
Critical
patent/AU4515885A/en

1988-11-24
Application granted
granted
Critical

1988-11-24
Publication of AU579387B2
publication
Critical
patent/AU579387B2/en

2005-07-18
Anticipated expiration
legal-status
Critical

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

239000003814
drug
Substances

0.000
title
1

229940124597
therapeutic agent
Drugs

0.000
title
1

239000002253
acid
Substances

0.000
abstract
2

125000003178
carboxy group
Chemical group

[H]OC(*)=O

0.000
abstract
2

206010028980
Neoplasm
Diseases

0.000
abstract
1

239000004952
Polyamide
Substances

0.000
abstract
1

125000003277
amino group
Chemical group

0.000
abstract
1

150000001875
compounds
Chemical class

0.000
abstract
1

238000001514
detection method
Methods

0.000
abstract
1

239000003937
drug carrier
Substances

0.000
abstract
1

238000004519
manufacturing process
Methods

0.000
abstract
1

239000000203
mixture
Substances

0.000
abstract
1

229920002647
polyamide
Polymers

0.000
abstract
1

230000001225
therapeutic effect
Effects

0.000
abstract
1

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations

A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent

A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K49/00—Preparations for testing in vivo

A61K49/001—Preparation for luminescence or biological staining

A61K49/0013—Luminescence

A61K49/0017—Fluorescence in vivo

A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules

A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule

A61K49/0036—Porphyrins

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K49/00—Preparations for testing in vivo

A61K49/001—Preparation for luminescence or biological staining

A61K49/0013—Luminescence

A61K49/0017—Fluorescence in vivo

A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent

A61K49/0052—Small organic molecules

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P35/00—Antineoplastic agents

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

C07K14/795—Porphyrin- or corrin-ring-containing peptides

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof

C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links

C07K5/06—Dipeptides

C07K5/06104—Dipeptides with the first amino acid being acidic

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof

C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links

C07K5/06—Dipeptides

C07K5/06104—Dipeptides with the first amino acid being acidic

C07K5/06113—Asp- or Asn-amino acid

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof

C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links

C07K5/08—Tripeptides

C07K5/0819—Tripeptides with the first amino acid being acidic

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof

C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links

C07K5/10—Tetrapeptides

C07K5/1021—Tetrapeptides with the first amino acid being acidic

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K38/00—Medicinal preparations containing peptides

Abstract

This invention relates to new therapeutic compositions for detection and/or treatment of mammalian tumors which comprises a fluorescent mono- or polyamide of an aminodicarboxylic acid and a tetrapyrrole containing at least one carboxy group of the structure:

wherein Z is the aminodicarboxylic acid residue less the amino group and X is the tetrapyrrole residue less the carboxy group and <> is an integer from 1 to 4 inclusive, and a pharmaceutical carrier therefor and a process for preparing the active tetrapyrrole compound.

AU45158/85A
1984-07-18
1985-07-18
New tetrapyrrole therapeutic agents

Expired

AU579387B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US06/631,925

US4675338A
(en)

1984-07-18
1984-07-18
Tetrapyrrole therapeutic agents

US631925

1984-07-18

Publications (2)

Publication Number
Publication Date

AU4515885A
true

AU4515885A
(en)

1986-03-27

AU579387B2

AU579387B2
(en)

1988-11-24

Family
ID=24533344
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU45158/85A
Expired

AU579387B2
(en)

1984-07-18
1985-07-18
New tetrapyrrole therapeutic agents

Country Status (11)

Country
Link

US
(1)

US4675338A
(en)

EP
(1)

EP0168832B1
(en)

JP
(2)

JPH0689000B2
(en)

AT
(1)

ATE94547T1
(en)

AU
(1)

AU579387B2
(en)

CA
(1)

CA1262862C
(en)

DE
(1)

DE3587579T2
(en)

DK
(1)

DK167768B1
(en)

HK
(1)

HK135994A
(en)

NO
(1)

NO169290C
(en)

SG
(1)

SG103194G
(en)

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU589957B2
(en)

1985-04-30
1989-10-26
Nippon Petrochemicals Company Limited
New tetrapyrrole therapeutic agents

US5275801A
(en)

1988-08-13
1994-01-04
Schering Aktiengesellschaft
13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds, process for their production and pharmaceutical agents containing them

Families Citing this family (97)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4649151A
(en)

1982-09-27
1987-03-10
Health Research, Inc.
Drugs comprising porphyrins

US4675338A
(en)

1984-07-18
1987-06-23
Nippon Petrochemicals Co., Ltd.
Tetrapyrrole therapeutic agents

JPS61186385A
(en)

1985-02-13
1986-08-20
Sato Yakugaku Kenkyusho:Kk
Deuteroporphyrin derivative and its salt

US4977177A
(en)

1985-04-30
1990-12-11
Nippon Petrochemicals Company, Ltd.
Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents

JPS625986A
(en)

1985-04-30
1987-01-12
Nippon Petrochem Co Ltd
Novel tetrapyrrole compound

US5066274A
(en)

1985-04-30
1991-11-19
Nippon Petrochemicals Company, Ltd.
Tetrapyrrole therapeutic agents

US4656186A
(en)

1985-04-30
1987-04-07
Nippon Petrochemicals Co., Ltd.
Tetrapyrrole therapeutic agents

US4849207A
(en)

1985-10-23
1989-07-18
Nihon Medi-Physics Co., Ltd.
Porphyrin derivatives

US5534506A
(en)

1986-01-02
1996-07-09
University Of Toledo
Use of purpurins, chlorins and purpurin- and chlorin-containing compositions

US5216012A
(en)

1986-01-02
1993-06-01
University Of Toledo
Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions

US5051415A
(en)

1986-01-02
1991-09-24
The University Of Toledo
Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions

US4772681A
(en)

1986-01-17
1988-09-20
Hamari Chemicals, Ltd.
Porphyrin derivatives

US4877872A
(en)

1986-06-24
1989-10-31
The University Of Toledo
Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes

US4920143A
(en)

1987-04-23
1990-04-24
University Of British Columbia
Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents

US5283255A
(en)

1987-01-20
1994-02-01
The University Of British Columbia
Wavelength-specific cytotoxic agents

US5171749A
(en)

1987-01-20
1992-12-15
University Of British Columbia
Wavelength-specific cytotoxic agents

US4883790A
(en)

1987-01-20
1989-11-28
University Of British Columbia
Wavelength-specific cytotoxic agents

US5095030A
(en)

1987-01-20
1992-03-10
University Of British Columbia
Wavelength-specific cytotoxic agents

JPH0629196B2
(en)

1987-12-01
1994-04-20
甲子郎梅村

Physiological action enhancer for tumor treatment by ultrasound

US5004811A
(en)

1987-12-24
1991-04-02
Nippon Petrochemicals Company, Ltd.
Tetrapyrrole aminocarboxylic acids

US5192788A
(en)

1988-05-23
1993-03-09
Georgia State University Foundation, Inc.
Porphyrin antiviral compositions

US5109016A
(en)

1988-05-23
1992-04-28
Georgia State University Foundation, Inc.
Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions

US4925736A
(en)

1988-07-06
1990-05-15
Long Island Jewish Medical Center
Topical hematoporphyrin

US4959356A
(en)

1989-05-26
1990-09-25
The United States Of America As Represented By The United States Department Of Energy
Porphyrins for boron neutron capture therapy

US4997639A
(en)

1989-11-27
1991-03-05
Nippon Petrochemicals Company, Limited
Method for detecting cholesterol deposited in bodies of mammals

US5053423A
(en)

1990-03-22
1991-10-01
Quadra Logic Technologies Inc.
Compositions for photodynamic therapy

US5238940A
(en)

1990-03-22
1993-08-24
Quadra Logic Technologies Inc.
Compositions for photodynamic therapy

US5219878A
(en)

1990-10-05
1993-06-15
Queen’s University
Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents

CA2093361C
(en)

1990-10-05
2002-04-23
Michel Ringuet
Porphyrin derivative

JP3154742B2
(en)

1991-04-30
2001-04-09
日本石油化学株式会社

Remedy for mammalian atherosclerosis

US5330741A
(en)

1992-02-24
1994-07-19
The Regents Of The University Of California
Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors

US5614502A
(en)

1993-01-15
1997-03-25
The General Hospital Corporation
High-pressure impulse transient drug delivery for the treatment of proliferative diseases

US5658892A
(en)

1993-01-15
1997-08-19
The General Hospital Corporation
Compound delivery using high-pressure impulse transients

JP3565442B2
(en)

1993-04-22
2004-09-15
新日本石油化学株式会社

Diagnostic and / or therapeutic agent for mammalian arthritis

US5492924A
(en)

1993-09-24
1996-02-20
Fox Chase Cancer Center
Phorbine derivatives and their use in the diagnosis and therapy of cancer

US5474910A
(en)

1993-10-15
1995-12-12
Alfano; Robert R.
Method and device for detecting biological molecules and/or microorganisms within a desired area or space

KR20040068613A
(en)

1994-03-25
2004-07-31
이소테크니카 인코포레이티드
Deuterated compound and composition for treating hypertension

US6334997B1
(en)

1994-03-25
2002-01-01
Isotechnika, Inc.
Method of using deuterated calcium channel blockers

JP2961074B2
(en)

1995-09-06
1999-10-12
明治製菓株式会社

Neovascular occlusive agents for photochemotherapy

US6350772B1
(en)

1996-11-06
2002-02-26
Meiji Seika Kaisha, Ltd.
Treatment of auto-immune diseases by photochemotherapy

WO2000000204A1
(en)

1997-02-14
2000-01-06
Miravant Pharmaceuticals, Inc.
Indium photosensitizers for pdt

WO1999007364A1
(en)

1997-08-05
1999-02-18
Meiji Seika Kaisha Ltd.
Immunosuppression by photochemotherapy

AU748625B2
(en)

1998-07-10
2002-06-06
Meiji Seika Kaisha Ltd.
Novel X-ray intercepting metal complexes of chlorin derivatives

JP2002534218A
(en)

1999-01-15
2002-10-15
ライトサイエンシーズコーポレイション

Non-invasive vascular therapy

US6602274B1
(en)

1999-01-15
2003-08-05
Light Sciences Corporation
Targeted transcutaneous cancer therapy

US6454789B1
(en)

1999-01-15
2002-09-24
Light Science Corporation
Patient portable device for photodynamic therapy

US20030114434A1
(en)

1999-08-31
2003-06-19
James Chen
Extended duration light activated cancer therapy

US7897140B2
(en)

1999-12-23
2011-03-01
Health Research, Inc.
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents

EP1262179A4
(en)

2000-02-17
2004-06-23
Meiji Seika Kaisha
Photodynamic therapy for selectively closing neovasa in eyeground tissue

JP2004523501A
(en)

2000-12-15
2004-08-05
マイトコー

Cobalt-porphyrin complexes and their use as obesity suppressants

EP1467760A2
(en)

2002-01-23
2004-10-20
Light Sciences Corporation
Systems and methods for photodynamic therapy

CA2490692A1
(en)

2002-06-27
2004-01-08
Health Research, Inc.
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy

US7053210B2
(en)

2002-07-02
2006-05-30
Health Research, Inc.
Efficient synthesis of pyropheophorbide a and its derivatives

IL152900A0
(en)

2002-11-17
2003-06-24
Yeda Res & Dev
Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

US20080269846A1
(en)

2003-03-14
2008-10-30
Light Sciences Oncology, Inc.
Device for treatment of blood vessels using light

US10376711B2
(en)

2003-03-14
2019-08-13
Light Sciences Oncology Inc.
Light generating guide wire for intravascular use

CN2885311Y
(en)

2006-01-18
2007-04-04
郑成福
Via urethra prostate therapeutic equipment using photodynamic therapy

US20060141049A1
(en)

2003-11-12
2006-06-29
Allergan, Inc.
Triamcinolone compositions for intravitreal administration to treat ocular conditions

US20070224278A1
(en)

2003-11-12
2007-09-27
Lyons Robert T
Low immunogenicity corticosteroid compositions

US20050101582A1
(en)

2003-11-12
2005-05-12
Allergan, Inc.
Compositions and methods for treating a posterior segment of an eye

JP2007518804A
(en)

2004-01-20
2007-07-12
アラーガン、インコーポレイテッド

Composition for topical ophthalmic treatment preferably containing triamcinolone acetonide and hyaluronic acid

US20050244463A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Sustained release intraocular implants and methods for treating ocular vasculopathies

US9498457B2
(en)

2004-04-30
2016-11-22
Allergan, Inc.
Hypotensive prostamide-containing biodegradable intraocular implants and related implants

US20050244458A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Sustained release intraocular implants and methods for treating ocular neuropathies

US20050244471A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods

US20050244478A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Anti-excititoxic sustained release intraocular implants and related methods

US8455656B2
(en)

2004-04-30
2013-06-04
Allergan, Inc.
Kinase inhibitors

US8147865B2
(en)

2004-04-30
2012-04-03
Allergan, Inc.
Steroid-containing sustained release intraocular implants and related methods

US20050244472A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods

US20050244461A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Controlled release drug delivery systems and methods for treatment of an eye

BRPI0510485A
(en)

2004-04-30
2007-11-13
Allergan Inc

biodegradable intravitreal tyrosine kinase inhibitor implants

US7771742B2
(en)

2004-04-30
2010-08-10
Allergan, Inc.
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods

US8722097B2
(en)

2004-04-30
2014-05-13
Allergan, Inc.
Oil-in-water method for making polymeric implants containing a hypotensive lipid

US7799336B2
(en)

2004-04-30
2010-09-21
Allergan, Inc.
Hypotensive lipid-containing biodegradable intraocular implants and related methods

US20050244500A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Intravitreal implants in conjuction with photodynamic therapy to improve vision

US20050244465A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Drug delivery systems and methods for treatment of an eye

US8425929B2
(en)

2004-04-30
2013-04-23
Allergan, Inc.
Sustained release intraocular implants and methods for preventing retinal dysfunction

US8673341B2
(en)

2004-04-30
2014-03-18
Allergan, Inc.
Intraocular pressure reduction with intracameral bimatoprost implants

US8591885B2
(en)

2004-04-30
2013-11-26
Allergan, Inc.
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems

US7993634B2
(en)

2004-04-30
2011-08-09
Allergan, Inc.
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods

US8119154B2
(en)

2004-04-30
2012-02-21
Allergan, Inc.
Sustained release intraocular implants and related methods

US20070059336A1
(en)

2004-04-30
2007-03-15
Allergan, Inc.
Anti-angiogenic sustained release intraocular implants and related methods

US20050244462A1
(en)

2004-04-30
2005-11-03
Allergan, Inc.
Devices and methods for treating a mammalian eye

CA2573668A1
(en)

2004-07-12
2006-02-16
Allergan, Inc.
Ophthalmic compositions and methods for treating ophthalmic conditions

WO2006043965A1
(en)

2004-10-14
2006-04-27
Allergan, Inc.
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

US20070142880A1
(en)

2005-11-07
2007-06-21
Barnard William L
Light delivery apparatus

WO2007103427A2
(en)

2006-03-06
2007-09-13
Wang Xiang H
Medical use of bilirubin and its structural analogues

CN100369914C
(en)

2006-04-30
2008-02-20
中国人民解放军总医院
3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine

CN100408581C
(en)

2006-04-30
2008-08-06
中国人民解放军总医院
3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine

JP5323693B2
(en)

2006-06-30
2013-10-23
ライト、サイエンシーズ、オンコロジー、インコーポレイテッド

Composition of chlorin e6 derivative as photoactive agent and method for producing chlorin e6 derivative

US8969415B2
(en)

2006-12-01
2015-03-03
Allergan, Inc.
Intraocular drug delivery systems

FR2914302A1
(en)

2007-03-30
2008-10-03
Sanofi Pasteur Sa

PROCESS FOR PREPARING PORPHYRIN DERIVATIVES, SUCH AS PROTOPORPHYRIN (IX) AND INTERMEDIATE SYNTHESIS

US7911053B2
(en)

2007-04-19
2011-03-22
Marvell World Trade Ltd.
Semiconductor packaging with internal wiring bus

US8318794B2
(en)

2008-11-25
2012-11-27
Science Group Pty. Ltd.
Method of use of porphyrins in preparing a medicament for sonodynamic therapy and a method of sonodynamic therapy using porphyrins

PT2498783T
(en)

2009-11-09
2018-11-29
Allergan Inc
Compositions and methods for stimulating hair growth

WO2014071138A1
(en)

2012-11-02
2014-05-08
Lewis Thomas J
Disease detection and treatment through activation of compounds using external energy

RU2641021C2
(en)

2013-02-15
2018-01-17
Аллерган, Инк.
Implant for prolonged drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4393071A
(en)

1975-03-17
1983-07-12
Naoharu Fujii
Method of treating gastric, mammary, lung and uterus tumors

JPS53112900A
(en)

1977-03-14
1978-10-02
Ajinomoto Co Inc
Porphyrin derivative

JPS58201791A
(en)

1982-05-19
1983-11-24
Katsuo Unno
Hematoporphyrin derivative

US4649151A
(en)

1982-09-27
1987-03-10
Health Research, Inc.
Drugs comprising porphyrins

DE3381616D1
(en)

1982-09-27
1990-07-05
Photofrin Medical Inc

CLEANED HEMAF 3381400 INCUBE FOR DIAGNOSIS AND TUMOR TREATMENT AND METHOD.

JPS60158686A
(en)

1984-01-27
1985-08-20
Matsushita Electric Ind Co Ltd
Semiconductor laser

JPS60158687A
(en)

1984-01-27
1985-08-20
Matsushita Electric Ind Co Ltd
Semiconductor laser

US4693885A
(en)

1984-07-18
1987-09-15
Nippon Petrochemicals Co., Ltd.
Tetrapyrrole therapeutic agents

US4675338A
(en)

1984-07-18
1987-06-23
Nippon Petrochemicals Co., Ltd.
Tetrapyrrole therapeutic agents

1984

1984-07-18
US
US06/631,925
patent/US4675338A/en
not_active
Expired – Lifetime

1985

1985-07-18
JP
JP60158687A
patent/JPH0689000B2/en
not_active
Expired – Lifetime

1985-07-18
DE
DE85108987T
patent/DE3587579T2/en
not_active
Expired – Lifetime

1985-07-18
AU
AU45158/85A
patent/AU579387B2/en
not_active
Expired

1985-07-18
NO
NO852871A
patent/NO169290C/en
not_active
IP Right Cessation

1985-07-18
JP
JP60158686A
patent/JPH0688902B2/en
not_active
Expired – Lifetime

1985-07-18
CA
CA487040A
patent/CA1262862C/en
not_active
Expired

1985-07-18
EP
EP85108987A
patent/EP0168832B1/en
not_active
Expired – Lifetime

1985-07-18
DK
DK326785A
patent/DK167768B1/en
not_active
IP Right Cessation

1985-07-18
AT
AT85108987T
patent/ATE94547T1/en
not_active
IP Right Cessation

1994

1994-07-26
SG
SG103194A
patent/SG103194G/en
unknown

1994-12-01
HK
HK135994A
patent/HK135994A/en
not_active
IP Right Cessation

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU589957B2
(en)

1985-04-30
1989-10-26
Nippon Petrochemicals Company Limited
New tetrapyrrole therapeutic agents

US5275801A
(en)

Also Published As

Publication number
Publication date

JPH0689000B2
(en)

1994-11-09

AU579387B2
(en)

1988-11-24

NO169290B
(en)

1992-02-24

CA1262862A
(en)

1989-11-14

HK135994A
(en)

1994-12-09

DE3587579T2
(en)

1994-02-17

SG103194G
(en)

1994-10-28

EP0168832A2
(en)

1986-01-22

DE3587579D1
(en)

1993-10-21

EP0168832B1
(en)

1993-09-15

JPH0688902B2
(en)

1994-11-09

CA1262862C
(en)

1989-11-14

NO852871L
(en)

1986-01-20

DK326785A
(en)

1986-01-19

DK167768B1
(en)

1993-12-13

JPS6183186A
(en)

1986-04-26

US4675338A
(en)

1987-06-23

EP0168832A3
(en)

1988-05-04

JPS61129163A
(en)

1986-06-17

DK326785D0
(en)

1985-07-18

NO169290C
(en)

1992-06-03

ATE94547T1
(en)

1993-10-15

Contact information